A*star's genome institute of singapore, nanostring and next level genomics establish joint lab to advance studies of complex diseases with spatial genomics

Singapore--(business wire)--a*star's genome institute of singapore (gis), nanostring® technologies, inc. (nasdaq: nstg), and next level genomics (nlg), today announced the establishment of a joint laboratory in singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response. the new lab, called the space-dx lab (spatial atlas of clinical evolution of disease), will harness spatial multiomic (gene and protein expression).
NSTG Ratings Summary
NSTG Quant Ranking